Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Closes Previously Announced Stock Placement; Nets $18.4M

NEW YORK (GenomeWeb News) — Sequenom has netted $18.4 million after selling $20 million of its common stock to “several new and existing” institutional investors, the company said today.
 
As a result, the company’s shares were up 9.12 percent, or $.30, at $3.59 in mid-afternoon trading today.
 
As GenomeWeb Daily News reported last Wednesday, Sequenom said it would sell 6.7 million shares at $3 apiece, a 1-cent premium over the stock’s closing price at that time.
 
Lehman Brothers and Rodman & Renshaw acted as placement agents for the transaction.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.